tbuckley/cabot-search huggingface dataset:
A Phase II Trial of Prophylactic Anakinra to Prevent Neurotoxicity in Patients Receiving Anti-CD19 CAR T-Cell Therapy for Relapsed or Refractory Lymphoma: Final Results from Cohort 2
Authors: Karthik Nath, Sean M. Devlin, Craig S Sauter, Maria Lia Palomba, Gunjan L. Shah, Parastoo Bahrami Dahi, Richard J. Lin, Michael Scordo, Miguel-Angel Perales, Lori A. Leslie, Roni Shouval, Sara Bekele, Elizabeth Cathcart, Elena Mead, Bianca Santomasso, Andrei Holodny, Renier Brentjens, Isabelle Riviere, Michel Sadelain, Jae H. Park
Journal: Blood (2023)
Long-Term Bleeding Protection, Sustained FIX Activity, Reduction of FIX Consumption and Safety of Hemophilia B Gene Therapy: Results from the HOPE-B Trial 3 Years after Administration of a Single Dose of Etranacogene Dezaparvovec in Adult Patients with Severe or Moderately Severe Hemophilia B
Authors: Steven Pipe, Paul van der Valk, Peter Verhamme, Peter Kampmann, Frank W.G. Leebeek, Michiel Coppens, Karina Meijer, Priyanka Raheja, Nigel S. Key, Nathan Visweshwar, Guy Young, Richard S. Lemons, Robert Klamroth, Wolfgang Miesbach, Jan Astermark, Niamh O'Connell, Rashid Saeed Kazmi, Nicholas Galante, Sandra LeQuellec, Paul Monahan, Cedric R. Hermans
Journal: Blood (2023)
Mechanisms of Red Blood Cell Splenic Filtration Revealed By Multiscale Modeling and in-Vitro Microfluidic Experiments
Authors: Zhangli Peng, Alexis Moreau, François Yaya, Huije Lu, Anagha Surendranath, Anne Charrier, Benoit Dehapiot, Emmanuelle Helfer, Annie Viallat
Journal: Blood (2023)
Drug Response Profiling Informs Personalized Bridging to Cell Therapy for Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
Authors: Fabio D. Steffen, Andrej Lissat, Julia Alten, Cornelia Eckert, Nicole Bodmer, Bodil E. Thorhauge Als-Nielsen, Adriana Balduzzi, Barbara Buldini, Sarah Elitzur, Andras Kriston, Gergely Nyiri, Imre Västrik, Ferenc Kovacs, Francesco Ceppi, Lucie Sramkova, Larissa Schori, Arianna Arpagaus, Silvia Gutnik, Andishe Attarbaschi, Birgitte Klug Albertsen, Jeanette Greiner, Marc Ansari, Judith M. Boer, Elad Jacoby, Martin Stanulla, Uri Ilan, Peter M. Hoogerbrugge, Tim Lammens, Barbara De Moerloose, Petter Svenberg, Nicolas von der Weid, David O'Connor, Hélène Cavé, Franco Locatelli, Martin Schrappe, André Baruchel, Andreas Kulozik, Kjeld Schmiegelow, Gunnar Cario, Arend von Stackelberg, Peter Horvath, Beat Bornhauser, Jean-Pierre Bourquin
Journal: Blood (2023)
Methyl-CpG Binding Domain Protein MBD2 Is a Targetable Vulnerability in <i>TET2</i> Mutant Myeloid Neoplasia
Authors: Dongxu Jiang, Yihong Guan, Shinjini Ganguly, Aysegul Balyimez, Andrew Muskara, Divya Jyoti Singh, Simona Pagliuca, Daniel Vail, Yahan Zhang, Jill Durkin, Naomi Kawashima, Xiaorong Gu, Carmelo Gurnari, Jaroslaw P. Maciejewski, Omar Mian, Babal K. Jha
Journal: Blood (2023)
Oral Anticoagulant (OAC) Use Among Medicare Patients Newly Diagnosed with Venous Thromboembolism (VTE): Factors Associated with Treatment Status
Authors: James C Coons, Aolin Wang, Dominick Latremouille-Viau, Cristina Russ, Dong Cheng, Robert Stellhorn, Feng Dai, David R Steffen, Abigail Zion, Serina Deeba, Dionne M Hines
Journal: Blood (2023)
Discovery and Development of CD70 As a Cellular Therapy Target in High Risk Multiple Myeloma
Authors: Corynn Kasap, Adila Izgutdina, Bonell Patino Escobar, Yu-Hsiu Tony Lin, Huimin Geng, Gianina Wicaksono, Daphne Dupere-Richer, Emilio Ramos, Abhilash Barpanda, Anjanaa Vijayanarayanan, Fernando Salangsang, Paul Phojanakong, Juan Antonio Camara Serrano, Veronica Steri, William Karlon, Mala Shanmugam, Lawrence H. Boise, Benjamin G. Barwick, Jonathan D. Licht, Arun P Wiita
Journal: Blood (2023)
Acute Myeloid Leukemia (AML) Patients with Myelodysplasia (MDS) Related-Gene Mutations in First Complete Remission (CR1) Found to Have Benefit from Allogeneic Hematopoietic Stem Cell Transplant (HCT)
Authors: Ayman Sayyed, Taehyung Simon Kim, Silvia Park, Jae-Sook Ahn, Aly Karsan, Marie-France Gagnon, Julie Bergeron, Hee-Je Kim, Hyeoung-Joon Kim, David Sanford, Andre C. Schuh, Dennis Dong Hwan Kim
Journal: Blood (2023)
Efficacy of Cord Blood Transplantation for the Management of Chronic Myelomonocytic Leukemia: A Registry-Based Study in Japan
Authors: Shuhei Kurosawa, Yoshimitsu Shimomura, Ken Ishiyama, Kyoko Fuse, Yutaka Shimazu, Noriko Doki, Naoyuki Uchida, Masatsugu Tanaka, Satoshi Takahashi, Masatoshi Sakurai, Hikaru Kobayashi, Yuta Katayama, Satoru Takada, Kazutaka Ozeki, Hirohisa Nakamae, Fumihiko Ishimaru, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Hidehiro Itonaga
Journal: Blood (2023)
Single Cell Analysis of Genes Involved in Asymmetric Hematopoietic Stem Cell (HSC) Division in Chronic Myeloid Leukemia (CML) : Evidence of the Regulation of Tetraspanin CD63 during Leukemia Progression
Authors: Christophe Desterke, Annelise Bennaceur Griscelli, Ali Turhan
Journal: Blood (2023)
A Multicenter Retrospective Study to Understand the Clinical Characteristics, Treatment Patterns, and Resource Utilization for Patients with Chronic Lymphocytic Leukemia: CREEK Study
Authors: Ahmad Alhuraiji, Ayman Alhejazi, Mohamed Samra, Bhausaheb Bagal, Miguel Arturo Pavlovsky, Macarena Roa, Shang-Ju Wu, Efreen H Montano Figueroa, Veena Selvaratnam, Chee-Yen Lin, Pushpalata K, Akemi Ishikawa, Francisco Gonzalez Hernandez
Journal: Blood (2023)
A Novel Prediction Model for BK Virus Associated Hemorrhagic Cystitis in Acute Leukemia Patients Following Allogenic Hematopoietic Cell Transplantation: A Retrospective Cohort Study
Authors: Xueqi Li, Peng Zhao, Zhuoyu An, Haixia Fu, Xiaolu Zhu, Yun He, Fengrong Wang, Yuanyuan Zhang, Xiaodong Mo, Wei Han, Jingzhi Wang, Yu Wang, Huan Chen, Yuhong Chen, Xiangyu Zhao, Lanping Xu, Kaiyan Liu, Yanchen Hua, Yuan Kong, Yingjun Chang, Xiaojun Huang, Xiaohui Zhang
Journal: Blood (2023)
Patients with Chronic Lymphocytic Leukemia Carrying t(14;19) Display a Distinctive Transcriptomic Profile and Adverse Outcome, Which Might be Overcome Continuous Therapy with BTK Inhibitors. an Italian Campus CLL and Eric Study
Authors: Andrea Visentin, Enrico Gaffo, Moritz Furstenau, Jennifer A. Woyach, Panagiotis Baliakas, Kerry A Rogers, Cecelia Miller, Claudia Haferlach, Karla Plevova, David Graham Oscier, Zadie Davis, Florence Nguyen Khac, Eleonora Roncaglia, Gian Matteo Rigolin, Anastasia Athanasiadou, Fanny Baran-Marszak, Alberto Valiente, Maria Jose Terol, Pau Abrisqueta, Blanca Espinet, Anna Puiggros, Annalisa Martines, Laura Bonaldi, Francesca Romana Mauro, Lydia Scarfo, Thomas Chatzikonstantinou, Eugen Tausch, Karl Anton Kreuzer, Arnon P. Kater, Francesc Bosch, Michael Doubek, Panayiotis Panayiotidis, Olga Kalashnikova, Federica Frezzato, Monica Facco, Valeria Ruocco, Alessia Buratin, Silvia Orsi, Alessandro Cellini, Francesco Angotzi, Chiara Adele Cavarretta, Ivan Zatta, Andrea Serafin, Robin Foa, Barbara F. Eichhorst, Antonio Cuneo, Kostas Stamatopoulos, Paolo Ghia, Stefania Bortoluzzi, Livio Trentin
Journal: Blood (2023)
Teclistamab in Relapsed Refractory Multiple Myeloma Patients on Dialysis: A French Experience
Authors: Florence Lachenal, Pierre Lebreton, Sylvie Bouillie, Gian Matteo Pica, Hassina Aftisse, Laurent Pascal, Lydia Montes, Margaret Macro, Marguerite Vignon, Stephanie Harel, Mariana Fernandez, Chanaz Louni, Antoine Huart, Aurore Perrot
Journal: Blood (2023)
Real-Life Experience of the Combination of Daratumumab, Bortezomib, Melphalan, and Prednisone (DVMP) in Patients with Newly Diagnosed Multiple Myeloma Ineligible for Autologous Stem-Cell Transplantation
Authors: Amalia Domingo-González, Rafael Alonso Fernández, Ana Jiménez, Teresa De Soto Alvarez, Ana Lerma, Virginia Pradillo Fernandez, Gonzalo Benzo Callejo, Jose Sanchez-Pina, Elena Landete, Alberto Velasco, Marina Menéndez Cuevas, Mónica María López Riñón, Andrés Ramírez López, Alberto Lopez Garcia, María-Jesús Blanchard, Elham Askari
Journal: Blood (2023)
Determinants of Response to Anti CD-19 CAR-T Cells for Diffuse Large B-Cell Lymphoma in Pre-Treatment Peripheral Blood Mononuclear Cells Using Single-Cell RNA-Seq
Authors: Ron Ram, Yonatan Katzenelenbogen, Anna Gurevich Shapiro, Eitan Winter, Oren Barboy, Mor Zada, Shahar Halevi, Eyal David, Irit Avivi Mazza, Ido Amit
Journal: Blood (2023)
The Ig Superfamily Ligand B7H6 Subjects Activated T Cells to NK Cell Surveillance and Limits CAR T Cell Persistence
Authors: Mirco Julian Friedrich, Michael Kilian, Kevin Hai-Ning Lu, Selina Jansky, Julius Michel, Anna Keib, David Vonhören, Nicolaj Hackert, Markus Hahn, Adelheid Cerwenka, Felix Sahm, Frank Westermann, Peter Dreger, Marc S. Raab, Nadja M. Meindl-Beinker, Matthias Ebert, Lukas Bunse, Carsten Müller-Tidow, Michael Schmitt, Michael Platten
Journal: Blood (2023)
Impact of Sequence Uniqueness on MRD Monitoring in NGS Immunoglobulin Sequencing: An Analysis of Ig Loci Among &amp;gt;1200 Diffuse Large B-Cell Lymphoma Patients Tested By Clonoseq
Authors: Heidi Simmons, Lik Wee Lee, April Lo, Kipp Akers, Ilan M. Kirsch, Allison P. Jacob
Journal: Blood (2023)
Calibrated Release IL15 Bivalent CD33 and/or FLT3 and NOT Emcn Logic Gated Gene Circuit CAR-NK Cell Therapy (SENTI-202) in Venetoclax Resistant Patient Derived Xenograft <i>Acute Myeloid Leukemia</i> Models
Authors: Muharrem Muftuoglu, Mahesh Basyal, Li Li, Jiangxing Lv, Lauren B. Ostermann, Ran Zhao, Baozhen Ke, Hiroki Akiyama, Po Yee Mak, Bing Z. Carter, Han Deng, Yongshuai Li, Brian S. Garrison, Kanya L. Rajangam, Michael Andreeff
Journal: Blood (2023)
<i>Coronado CLL</i>: A Phase Ib/II Trial of <i>Co</i>mbination <i>R</i>p-3500 and <i>O</i>laparib in DNA Damage Repair Pathway <i>D</i>eficient Relapsed/Refract <i>o</i>ry <i>C</i>hronic <i>L</i>ymphocytic <i>L</i>eukemia
Authors: Boyu Hu, Adam S Kittai, Kenneth Boucher, Tony Pomicter, Deborah M. Stephens
Journal: Blood (2023)
Time-Limited Bendamustine, Rituximab, and Venetoclax (BR-VR) in Untreated Chronic Lymphocytic Leukemia (CLL): High Rates of Undetectable Minimal Residual Disease Remissions
Authors: Andrew H. Lipsky, Brian T. Hill, Allison Winter, Spencer Henick Bachow, Aaron D. Viny, Todd L. Rosenblat, Joseph Jurcic, Nicole Lamanna
Journal: Blood (2023)
French Monocentric Experience of Outpatient Step-up Dosing of Teclistamab in Relapsed Refractory Multiple Myeloma
Authors: Benjamin Hebraud, Miguel Granell, Leopoldine Lapierre, Pierre Luc Mouchel, Guillaume Beziat, Nina Sicard, Maeva Bonneau, Jules Higue, Florence Sougy, Sophie Perriat, Charlotte Morel, Pierre Bories, Jill Corre, Herve Avet Loiseau, Christian Recher, Aurore Perrot
Journal: Blood (2023)
Minimal Residual Disease-Guided Combination of Ibrutinib and Venetoclax Compared to FCR in Untreated Patients with CLL of Intermediate Risk : Interim Results of MRD Kinetics in the Eradic Trial from the Filo Group
Authors: Anne-Sophie Michallet, Anne Quinquenel, Remi Letestu, Tavernier Magali, Stéphane Morisset, Therese Aurran, Kamel Laribi, Florence Cymbalista, Vincent Levy, Laurence Simon, Damien Roos Weil, Veronique Leblond, Marie Sarah Dilhuydy, Cecile Tomowiak, Caroline Dartigeas, Romain Guieze, Olivier Tournilhac, Emmanuelle Ferrant, Sophie De Guibert, Pierre Feugier, Fatiha Merabet, Stéphane Lepretre, Philippe Carassou, Julie Gay, Benedicte Hivert, Luc Matthieu Fornecker, Jehan Dupuis, Lysiane Molina, Bruno Villemagne, Guillaume Cartron, Bernard Drenou, Béatrice Mahé, Omar Benbrahim, Xavier Cahu, Christelle Portois, Loic Ysebaert, Florence Nguyen Khac, Valerie Rouillé, Alain Jacques Delmer
Journal: Blood (2023)
Ibrutinib, Fludarabine, Cyclophosphamide and Obinutuzumab (iFCG) for Firstline Treatment of Patients with CLL with Mutated <i>IGHV</i> and without Del(17p)/ <i>TP53</i> Mutation: Six-Year Follow-up Analyses
Authors: Nitin Jain, Philip Thompson, Akhil Jain, Jan A. Burger, Alessandra Ferrajoli, Jayastu Senapati, Koichi Takahashi, Mahesh Swaminathan, Zeev Estrov, Gautam Borthakur, Prithviraj Bose, Tapan M. Kadia, Naveen Pemmaraju, Koji Sasaki, Divyam Bansal, Marina Y. Konopleva, Elias Jabbour, Naveen Garg, Xuemei Wang, Rashmi Kanagal-Shamanna, Keyur P. Patel, Wei Wang, Sa A. Wang, Jeffrey L. Jorgensen, Wanda Lopez, Ana Ayala, William Plunkett, Varsha Gandhi, Hagop M. Kantarjian, Susan M. O'Brien, Michael J. Keating, William G. Wierda
Journal: Blood (2023)
Fixed-Duration Pirtobrutinib Combined with Venetoclax ± Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia: Updated Results, Including MRD Data, from the BRUIN Phase 1b Study
Authors: Lindsey E. Roeker, Jennifer A. Woyach, Chan Y. Cheah, Catherine C Coombs, Nirav N. Shah, William G. Wierda, Manish Patel, Donald E. Tsai, Binoj Nair, Chunxiao Wang, Xiang Zhao, Narasimha Marella, Caleb Ho, Samuel McNeely, Jennifer R. Brown
Journal: Blood (2023)
Quality of Life and Comorbidities of Adult Survivors of Allogeneic Hematopoietic Cell Transplant Versus Their Siblings
Authors: Nikki Blosser, Sunita Ghosh, Bhavi Desai, Nicole Crisp, Baljit Randhawa, Grace Beda, Andrew Daly, Jan Storek, Kareem Jamani
Journal: Blood (2023)
The Deubiquitinase CYLD Acts As an Oncogene in a Cellular Model of Chronic Lymphocytic Leukemia
Authors: Marina Gerousi, Georgios Gavriilidis, Sofoklis Keisaris, Artemis Kourouni, Aspasia Orfanou, Anastasia Iatrou, Athanasios Pseftogkas, George Mosialos, Eleni Theodosiou, Anastasia Chatzidimitriou, Fotis Psomopoulos, Paolo Ghia, Kostas Stamatopoulos, Konstantinos Xanthopoulos
Journal: Blood (2023)
Incidence of Richter Transformation in Patients with Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL): A Cohort Study Evaluating Different Therapeutic Eras
Authors: Paul J. Hampel, Kari G. Rabe, Yucai Wang, Steven R Hwang, Saad S. Kenderian, Eli Muchtar, Jose F. Leis, Amber Koehler, Mazie Tsang, Ricardo Parrondo, Rachel Bubik, Susan Marie Schwager, Curtis A. Hanson, Esteban Braggio, Susan L. Slager, Min Shi, Daniel L. Van Dyke, Timothy G. Call, Neil E. Kay, Wei Ding, Sameer A. Parikh
Journal: Blood (2023)
Adoptive Therapy with Cytomegalovirus-Specific Cytotoxic T Lymphocytes for Refractory Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Zhonghui Jiang, Zhiping Fan, Hui Xu, Na Xu, Tian Zhang, Huiwen Xue, Ren Lin, Zhixiang Wang, Ling Jiang, Jing Sun, Li Xuan
Journal: Blood (2023)
Integrative Multi-Omics Analysis of Tumor-Immune Microenvironment in Multiple Myeloma: Novel Insights and Therapeutic Implications
Authors: Elina Alaterre, Nicolas Robert, Guilhem Requirand, Amélie Machura, Hugues De Boussac, Laure Vincent, Charles Herbaux, Angélique Bruyer, Jerome Moreaux
Journal: Blood (2023)
Real-World Effectiveness of Asciminib in Patients with Chronic Myeloid Leukemia (CML) Harboring the T315I Mutation: A Global Chart Review Study of Patients Treated in the Asciminib Managed Access Program (MAP)
Authors: Dragana Milojkovic, Nicole Blijlevens, Yok-Lam Kwong, Uzma Zaidi, Fausto Castagnetti, Paolo Gallipoli, Maria Cristina Miggiano, Peter E Westerweel, Melissa Chen, M. Carmen Garcia Hernandez, William J. Kell, Pankit Vachhani, Neha Agarwal, Alessandra Colasante, Sridhar Meka, Aoife Smyth, Germano Ferreira, Jeroen J.W.M. Janssen
Journal: Blood (2023)
Characterization of Clonal Hematopoietic of Indeterminate Potential (CHIP) Mutations in an Imid-Naïve Multiple Myeloma (MM) Autologous Stem Cell Transplant (ASCT) Population: First Results from a Pre-Transplant Time Point in a Prospective, Longitudinal Study
Authors: Sahar Khan, Salman Basrai, Donna Reece, Sita D. Bhella, Vishal Kukreti, Anca Prica, A. Keith Stewart, Suzanne Trudel, Harjot Vohra, Chloe Yang, Sagi Abelson, Christine Chen
Journal: Blood (2023)
Molecular Expression Differences in Blood Mononuclear Cells in Patients with AL Amyloidosis
Authors: David Kaplan, Eric Christian, Jason Valent, Faiz Anwer, Shahzad Raza, Sandra Mazzoni, Christy J. Samaras, Louis S. Williams, Danai Dima, Kelly Shepherd, Jared Fennema, Sherry Fada, Megan Nakashima, Mazen Hanna, Hillard M. Lazarus, Jack Khouri
Journal: Blood (2023)
Diagnosis and Outcome of Patients with Idiopathic Hypereosinophilic Syndrome and Cardiac Involvement
Authors: Johannes Lübke, Anna Hohneck, Jan Leipe, Nicole Naumann, Alice Fabarius, Wolf-Karsten Hofmann, Georgia Metzgeroth, Theano Papavassilu, Andreas Reiter, Juliana Schwaab
Journal: Blood (2023)
Class III Obesity Is Associated with Worse Overall Survival in Previously Untreated Younger Patients with Acute Myeloid Leukemia Enrolled on SWOG 1203
Authors: Michelle Y. Zhang, Megan Othus, Kerry K McMillen, Harry P. Erba, Guillermo Garcia-Manero, John Pagel, Mohamed Sorror, Mary-Elizabeth M. Percival
Journal: Blood (2023)
A STAT3 Degrader Demonstrates Pre-Clinical Efficacy in Venetoclax Resistant Acute Myeloid Leukemia
Authors: Samarpana Chakraborty, Claudia Morganti, Joyoti Dey, Hui Zhang, Srinivas Aluri, Nadege Gitego, Kith Pradhan, Bianca Rivera, Yogesh Chutake, Anna Skwarska, Ioannis Mantzaris, Mendel Goldfinger, Eric J Feldman, Gaurav S Choudhary, Stefan Hubner, Yihua Qiu, Brandon D. Brown, Amit Verma, Evripidis Gavathiotis, Marina Y. Konopleva, Steven M. Kornblau, Jared Gollob, Keisuke Ito, Aditi Shastri
Journal: Blood (2023)
The MAGIC Algorithm Probability Predicts Long-Term Outcomes and Treatment Response to Second-Line Therapy for Acute Gvhd
Authors: Zachariah Defilipp, Haesook T. Kim, Nikolaos Spyrou, Steven Kowalyk, Gilbert Eng, Rahnuma Beheshti, Janna Baez, Francis A. Ayuk, Hannah Choe, Aaron Etra, Stephan Grupp, Elizabeth O Hexner, William J. Hogan, Carrie L. Kitko, Muna Qayed, Ran Reshef, Ingrid Vasova, Robert Zeiser, Rachel Young, James L.M. Ferrara, Ryotaro Nakamura, John Levine, Yi-Bin Chen
Journal: Blood (2023)
Simvastatin with Intrathecal Dexamethasone Reduces Neurotoxicity in Adults Receiving Chimeric Antigen Receptor (CAR) T-Cells Treatment
Authors: Nuttavut Sumransub, Cassie Seichter, Kateryna Kent, Ryan Shanley, Marie Hu, Daniel O'Leary, Najla H El Jurdi, Shernan G. Holtan, Brian Betts, Mark Juckett, Jeremy R. Allred, Veronika Bachanova, Jeffrey S Miller, Joseph E. Maakaron
Journal: Blood (2023)
Intracellular Retention of Tcrαβ/CD3 to Generate Novel Allogeneic CAR-T Cells (ThisCART19A) with Enhanced Antitumor Potency for Treating B-ALL
Authors: Yongxian HU, Guoqing Wei, Shan Fu, Pingnan Xiao, Jingjing Feng, Mingming Zhang, Xingbing Wang, Dongrui Wang, Jun Li, He Huang
Journal: Blood (2023)
Pharmacology of a CpG-Linked Anti-Mir-126 Oligonucleotide Targeting Acute Myeloid Leukemia (AML) in Rats and Non-Human Primates (NHP)
Authors: Lucy Ghoda, Kokilah Muthaiyah, Bin Amber Zhang, Marcin Kortylewski, James Simpson, Le Xuan Truong Nguyen, Marjorie Robbins, Guido Marcucci, Tim Synold
Journal: Blood (2023)
FORTITUDE: A Phase 2 Open-Label Study in Progress to Evaluate Etavopivat for the Treatment of Anemia in Patients with Lower-Risk Myelodysplastic Syndromes
Authors: Mikkael A. Sekeres, Uwe Platzbecker, Rasmus Heje Thomsen, Sam Wilson, Anne S. Renteria, Pierre Fenaux
Journal: Blood (2023)
Venetoclax Combined with “7+3” Induction Chemotherapy Induces High Rates of MRD-Negative Remission in Newly Diagnosed AML Patients Fit for Intensive Chemotherapy Irrespective of Age
Authors: Ioannis Mantzaris, Mendel Goldfinger, Nishi Shah, Annemarie Munoz, Aradhika Dhawan, Nicole Chambers, Karen Fehn, Joel Victor, Aditi Shastri, Kira Gritsman, Noah Kornblum, Alejandro Sica, Dennis L Cooper, Amit Verma, Mimi Kim, Ulrich Steidl, Eric J Feldman, Marina Y. Konopleva
Journal: Blood (2023)
Frailty Impact on Outcomes of Patients Undergoing Chimeric Antigen Receptor T-Cell (CAR T) Therapy at Princess Margaret Cancer Centre: A Prospective Pilot Study
Authors: Anca Prica, Tiana Coley, Rachel Aitken, Abi Vijenthira, Manjula Maganti, Samantha J Mayo, John Kuruvilla, Michael Crump, Sita D. Bhella, Robert Kridel, Vishal Kukreti, Chloe Yang, Shabbir MH Alibhai, Christine Chen
Journal: Blood (2023)
High Frequency of HLA-Class II B Cell Receptor Neoantigens in IGHV Mutated-CLL
Authors: Muhammed B. Sabdia, Melinda Burgess, Soi Cheng Law, Lauren A Thurgood, Stephen Kazakoff, Fiona Swain, Joshua W.D. Tobin, Peter Mollee, Ann-Marie Patch, Maher K Gandhi
Journal: Blood (2023)
Revumenib Maintenance Therapy Following Revumenib-Induced Remission and Transplant
Authors: Andrius Zucenka, Ghayas C. Issa, Martha Arellano, Sajad Khazal, Nandita Khera, Wendy Stock, Branko Cuglievan, Yu Gu, Huy Van Nguyen, Angela R. Smith, Eytan M. Stein
Journal: Blood (2023)
Development of a Phase 1 Study Evaluating the Activity of Modular CAR T for Multiple Myeloma (MCARTY) Targeting BCMA and CD19 for Improved Persistence
Authors: Lydia Sarah Hui Lee, Wen Chean Lim, Catriona Mactier, Juliana Dias Alves Pinto, Vitoria Pereira, Mhairi Vaughan, Louisa Green, Evie Lewin, John Garcia, Giulia Agliardi, Yashma Pathak, Riaz Jannoo, Leigh Wood, Bilyana Popova, Helen Holmes, Simon Thomas, Victoria Spanswick, William Wilson, Christopher Parrish, Rakesh Popat, Claire Roddie, Kwee Yong, Martin A. Pule
Journal: Blood (2023)
Lifestyle Behaviors and Health-Related Quality of Life in Long-Term Survivors of Acute Myeloid Leukemia: An International Survivorship Study By the Gimema, EORTC Quality of Life and Leukemia Groups
Authors: Fabio Efficace, Laura Cannella, Xavier Thomas, Meltem Kurt Yuksel, Silvia Maria Trisolini, Capria Saveria, Alberto Brini, Ernesta Audisio, Luca Maurillo, Roberto Massimo Lemoli, Annalisa Imovilli, Irina Panovska Stavridis, Martina Quattrone, Maria Ciccone, Nunzio Filardi, Nicola Fracchiolla, Daniele Vallisa, Monica Crugnola, Lorella Maria Antonia Melillo, Matevz Skerget, Marco Vignetti, Frederic Baron
Journal: Blood (2023)
Hypoimmune, Allogeneic CD22-Directed CAR T Cells That Evade Innate and Adaptive Immune Rejection for the Treatment of Large B Cell Lymphoma Patients That Are Relapsed/Refractory to CD19-Directed CAR T Cell Therapy
Authors: Adam Johnson, Hallee Wright, Xiaomeng Hu, Jeremy Kinder, Neal van Hoeven, Ouwen Liang, Brian Granger, Tori Duback, Chris Baldeviano, Sundeep Chandra, Trevor McGill, Boris Gorovits, Shannon Joyce, Sam Crocker, Anna Liang, Carrie Rocca, Jenny Migliaccio, Prasanna Kumar, Vasily Vagin, Kerrie Enger, Chi Young, Andrew McAlister, Sonja Schrepfer, Terry J. Fry
Journal: Blood (2023)
APAL2020SC Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias
Authors: Michele S. Redell, Todd A. Alonzo, Robert Gerbing, Jim Wang, Maureen M. O'Brien, Gwen Nichols, Laura Di Laurenzio, Sarah K. Tasian, C. Michel Zwaan, Dirk Reinhardt, E. Anders Kolb, Todd Cooper
Journal: Blood (2023)
Neutralization of IL-1β and P-Selectin Inhibition Attenuate Organ Injury in Mice with Sickle Cell Disease
Authors: Erica M.F. Gotardo, Lucas F.S. Gushiken, Pamela L Brito, Flavia C. Leonardo, Lidiane S. Torres, Sergei Agoulnik, Jiri Kovarik, Andreas Bruederle, John Millholland, Fernando Ferreira Costa, Nicola Conran
Journal: Blood (2023)
Autoimmune Cytopenia Associated with Indolent B-Cell Clones: A Large Multicentric Cohort Study
Authors: Yoann Zadro, Amélie Lusque, Heloise Rey, Julie Graveleau, Fanny Lemarie, Lenaig Le Clech, Corentin Orvain, Paul Albert Domnariu, Clement Gourguechon, Etienne Crickx, Kamel Laribi, Delphine Gobert, Leonce Adjoumani, Emilie Berthoux, Alban Deroux, Marie Durel, Mickael Ebbo, Jonathan Farhi, Sebastien Humbert, Vincent Jachiet, Pierre Cougoul, Jeremie Dion, Brice Castel, Clement Begey, Jean-Baptiste Rieu, Samuel Deshayes, Mathilde Devaux, Isabelle Durieu, Martin Gauthier, Jean-Francois Viallard, Nihal Martis, Jérôme Paillassa, Guillaume Denis, Sondess Hadj Khelifa, Christian Lavigne, Francois Lifermann, Guillaume Moulis, Arsene Mekinian, Loic Ysebaert, Marc Michel, Bertrand Godeau, Thibault Comont
Journal: Blood (2023)
Sexual Health in Young Adult Patients after Chimeric Antigen Receptor T-Cell Therapy
Authors: Acadia Buro, Vivian Irizarry Gatell, Hayden J Fulton, Rebecca Blackwell, Kellie Zambrano, Yvelise Rodriguez, Xiaoyin Li, Xuefeng Wang, Laura B. Oswald, Rawan Faramand
Journal: Blood (2023)
Phase I/II Clinical Trial Evaluating Azacitidine + Venetoclax + Donor Lymphocyte Infusion in Post-Transplant Relapse Myelodysplastic Syndromes and Acute Myeloid Leukemia: Preliminary Results of Ventograft, a GFM Study
Authors: Thomas Cluzeau, Marie Sebert, Michael Loschi, Lionel Ades, Sylvain Thepot, Martin Carre, Nicolas Duployez, Rosa Sapena, Fatiha Chermat, Claude Preudhomme, Pierre Fenaux, Marie Robin
Journal: Blood (2023)